- You can view the full Merck Ratings Report.
- Use our drugs section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
The vote on repealing and replacing Obamacare has been pulled from the House floor.
TheStreet's Adam Feuerstein answers reader questions about biotech stocks.
Merck KGaA shares tested one-year highs Friday after the Food & Drug Administration approved rare form of skin cancer treatment that could cost patients as much as $13,000 per month.